This webpage was last updated on 25/03/2014
ECRHS

European Community Respiratory Health Survey

 

Home Page
What is ECRHS I
What is ECRHS II
What is ECRHS III
Project Partners and    Funding
Co-ordinating Centre
Steering Committee
Working Groups
Reports
Questionnaires &    Protocols
Publications

Progress

Links
ERS Barcelona 2013

ECRHS I Participants and Financial Support

Co-ordinating Centre (London): P Burney, S Chinn, C Luczynska†, D Jarvis, E Lai.
Project Management Group:  P Burney (Project leader-UK) S Chinn (UK), C Luczynska † (UK),
D Jarvis (UK), P Vermeire † (Antwerp), H Kesteloot (Leuven), J Bousquet (Montpellier), D Nowak (Hamburg), the late J Prichard † (Dublin), R de Marco (Verona), B Rijcken (Groningen), JM Anto (Barcelona), J Alves (Oporto), G Boman (Uppsala), N Nielsen (Copenhagen), P Paoletti (Pisa).


Postal Survey Participating Centres:

 Algeria: Algiers (N. Ait-Khaled),Australia: Melbourne (M. Abramson, J. Kutin), Austria: Vienna (W. Popp) Belgium: Antwerp South, Antwerp Central (P. Vermeire, F van Bastelaer) Denmark: Aarhus ( R.Dahl, M.Iversen) Estonia: Tartu ( R. Jõgi), France: Bordeaux (A. Taytard) Grenoble (I. Pin, C. Pison), Nancy (D. Teculescu),Paris (F. Neukirch, R.Liard) Montpellier (J. Bousquet, J. Knani Germany: Erfurt ( H-E Wichmann, J. Heinrich) Hamburg ( H. Magnussen, D. Nowak),  Greece: Athens (N. Papageorgiou, P. Avarlis, M. Gaga, C. Marossis) Iceland: Reykjavik  (T. Gislason, D. Gislason)India: Mumbai (R. Chowgule), Ireland : Dublin (J .Prichard, S. Allwright, D. MacLeod)Kilkenny(Wexford), Italy: Pavia (I .Cerveri) Turin:  (M. Bugiani, C. Bucca, C. Romano) Verona: (R de Marco, L. Cascio, C. Campello) The Netherlands: Groningen, Bergen-op-Zoom, Geleen (B. Rijcken, A. Kremer) New Zealand: Auckland, Wellington, Christchurch, Hawkes Bay (J. Crane, S. Lewis)  Norway: Bergen  (A .Gulsvik, E. Omenaas)  Portugal : Coimbra (C. Loureiro, C. Chieira,R. Cordeiro), Lisbon ( R. Avila, R. Amaral Marques),Oporto (JA Marques, J. Alves),  Spain: Albacete (J. Martinez-Moratalla, E. Almar, A.Mateos, M. Arévalo, A. Sánchez, M. Vizcaya, X. Aguilar, A. Teixidó )  Barcelona (J.M. Antó, M. Kogevinas, J. Sunyer, F. Burgos, J. Castellsagué, J. Roca, JB. Soriano, A. Tobías) Galdakao: N. Muiñozguren , J. Ramos González, A. Capelastegui ) Huelva: (J. Maldonado Pérez A Pereira, J. Sánchez)  Oviedo (J. Quiros, I. Huerta, F. Payo) Sweden: Göteborg (N Lindholm, P Plaschke) Uppsala: (G Boman, C. Janson, E. Björnsson) Umeå  (L. Rosenhall, E. Norrman B. Lundbäck) Switzerland: Basel (U Ackermann- Liebrich, N. Künzli, A. Perruchoud) UK: Caerphilly (M. Burr, J. Layzell) Cambridge ( J. Stark) Ipswich (R. Hall) Norwich (B. Harrison) USA: Portland (S. Buist, W. Vollmer, M. Osborne)

 
 
 

ECRHS I Financial Support

 The following grants helped to fund the local studies.

Australia: Asthma Foundation of Victoria, Allen and Hanbury's, Belgium: Belgian Science Policy Office, National Fund for Scientific Research, Estonia:  Estonian Science Foundation, grant no 1088, France:  Ministère de la Santé, Glaxo France, Insitut Pneumologique d'Aquitaine, Contrat de Plan Etat-Région Languedoc-Rousillon, CNMATS, CNMRT (90MR/10, 91AF/6), Ministre delegué de la santé, RNSP, France; GSF, Germany: Bundesminister  für Forschung und Technologie, Greece: The Greek Secretary General of Research and Technology, Fisons, Astra and Boehringer-Ingelheim; India: Bombay Hospital Trust, Italy: Ministero dell'Università e della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto grant RSF n. 381/05.93, New Zealand: Asthma Foundation of New Zealand, Lotteries Grant Board, Health Research Council of New Zealand, Norway: Norwegian Research Council project no. 101422/310; Portugal: Glaxo Farmacêutica Lda, Sandoz Portugesa,  Spain:  Fondo de Investigación Sanitaria ( #91/0016-060-05/E, 92/0319 and #93/0393), Hospital General de Albacete, Hospital General Juan Ramón Jiménez,   Dirección Regional de Salud Pública (Consejería de Sanidad  del Principado de Asturias), CIRIT (1997 SGR 00079) and Servicio Andaluz de Salud;  Sweden: The
Swedish Medical Research Council, the Swedish Heart Lung Foundation, the Swedish Association against Asthma and Allergy; Switzerland: Swiss national Science Foundation grant 4026-28099; UK: National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority, USA: United States Department of Health, Education and Welfare Public Health Service (grant #2 S07 RR05521-28).

Acknowledgements: The co-ordination of this work was supported by the European Commission and the authors and participants are grateful to the late C. Baya and M. Hallen for their help during the study and K. Vuylsteek and the members of the COMAC for their support.

 

ECRHS II Participants and Financial Support


The Steering Committee for the ECRHS II were as follows:
U. Ackermann-Liebrich (University of Basel, Switzerland); N. Kuenzli (University of Basel, and University of Southern California, Los Angeles, USA); J.M. Antó and J. Sunyer (Institut Municipal d’ Investigació  Médica (IMIM-IMAS), Universitat  Pompeu Fabra (UPF), Spain); P. Burney (project leader), S Chinn, D. Jarvis, J. Knox and C. Luczynska (King’s College London, UK); I. Cerveri (University of Pavia, Italy); R. de Marco (University of Verona, Italy); T. Gislason (Iceland University Hospital, Iceland); J. Heinrich and M. Wjst (GSF–Institute of Epidemiology, Germany); C. Janson (Uppsala University, Sweden); B. Leynaert and F. Neukirch (Institut National de la Sante´ et de la Recherche Meidicale (INSERM),France); J. Schouten (University of Groningen, The Netherlands); C. Svanes (University of Bergen, Norway);P. Vermeire (University of Antwerp, Belgium).


ECHRS II Principal Investigators and senior scientific teams:
Australia: (M. Abramson, E.H Walters, J. Raven) Belgium: South Antwerp and Antwerp City (P. Vermeire, J. Weyler, M. van Sprundel, V. Nelen) Estonia: Tartu (R. Jõgi, A. Soon); France: Paris (F. Neukirch, B. Leynaert, R. Liard, M. Zureik), Grenoble (I. Pin, J. Ferran-Quentin); Germany: Erfurt (J. Heinrich, M. Wjst, C. Frye, I. Meyer); Iceland:Reykjavik (T. Gislason, E. Bjornsson, D. Gislason, K.B Jörundsdóttir); Italy: Turin (R. Bono, M. Bugiani, P.Piccioni, E. Caria, A. Carosso, E. Migliore, G. Castiglioni), Verona (R. de Marco, G. Verlato, E. Zanolin, S. Accordini, A. Poli, V. Lo Cascio, M. Ferrari, I. Cazzoletti), Pavia (A. Marinoni, S. Villani, M. Ponzio, F. Frigerio, M. Comelli, M. Grassi, I. Cerveri, A. Corsico); The Netherlands: Groningen and Geleen (J. Schouten,M. Kerkhof); Norway: Bergen (A. Gulsvik, E. Omenaas, C. Svanes, B. Laerum); Spain: Albacete (J. Martinez-Moratalla Rovira, E. Almar, M. Arévalo, C. Boix, G González, J.M. Ignacio García, J. Solera, J Damián), Galdakao (N. Muñozguren, J. Ramos, I. Urrutia, U. Aguirre )Barcelona (J. M. Antó, J. Sunyer, M. Kogevinas, J. P. Zock, X. Basagaña, A. Jaen, F. Burgos, C. Acosta), Huelva (J. Maldonado, A. Pereira, J.L. Sanchez), Oviedo (F. Payo, I . Huerta, A. de la Vega, L Palenciano, J Azofra, A Cañada); Sweden: Göteborg (K. Toren,L. Lillienberg, A. C. Olin, B. Balder, A. Pfeifer-Nilsson, R. Sundberg) Umea (E. Norrman, M. Soderberg, K. Franklin, B. Lundback, B. Forsberg, L. Nystrom); Uppsala (C. Janson, G. Boman, D. Norback, G. Wieslander,  M. Gunnbjornsdottir), Switzerland: Basle (N. Kuenzli, B. Dibbert, M. Hazenkamp, M. Brutsche, U. Ackermann-Liebrich); United Kingdom: Ipswich (D. Jarvis, R. Hall, D. Seaton), Norwich (D. Jarvis, B. Harrison)

 

ECRHS II Financial Support

 The following grants helped to fund the local studies.

Australia: National Health and Medical Research Council, Belgium: Antwerp: Fund for Scientific Research (grant code, G.0402.00), University of Antwerp, Flemish Health Ministry; Estonia: Tartu Estonian Science Foundation grant no 4350, France: Bordeaux: Institut Pneumologique d’Aquitaine; Grenoble:  Programme Hospitalier de Recherche Clinique—Direction de la Recherche Clinique (DRC) de Grenoble 2000 number 2610, Ministry of Health, Ministere de l’Emploi et de la Solidarite, Direction Generale de la Sante, Centre Hospitalier Universitaire (CHU) de Grenoble, Comite des Maladies Respiratoires de l’Isere; Montpellier: Programme Hospitalier de Recherche Clinique—DRC de Grenoble 2000 number 2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble, Ministere de l’Emploiet de la Solidarite, Direction Generale de la Sante, Aventis ( France), Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; Paris: Ministere de l’Emploi et de la Solidarite, Direction Generale de la Sante,Union Chimique Belge- Pharma (France),Aventis (France), Glaxo France, Programme Hospitalier de Recherche Clinique—DRC de Grenoble2000 number 2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble; Germany: Erfurt GSF—National Research Centre for Environment and Health, Deutsche Forschungsgemeinschaft (grant code, FR1526/1-1) Hamburg: GSF—National Research Centre for Environment and Health, Deutsche Forschungsgemeinschaft (grant code, MA 711/4-1) Iceland: Reykjavik, Icelandic Research Council, Icelandic University Hospital Fund; Italy: Pavia GlaxoSmithKline Italy, Italian Ministry of University and Scientific and Technological Research (MURST),Local University Funding for Research 1998 and 1999;Turin: Azienda Sanitaria Locale 4 Regione Piemonte (Italy), Azienda Ospedaliera Centro Traumatologico Ospedaliero/Centro Traumatologico Ortopedico—Istituto Clinico Ortopedico Regina Maria Adelaide Regione Piemonte Verona:  Ministero dell’Universita´ e della Ricerca Scientifica (MURST), Glaxo Wellcome spa, Norway: Bergen: Norwegian Research Council, Norwegian Asthma and Allergy Association, Glaxo Wellcome AS, Norway Research Fund; Spain: Fondo de Investigacion Santarias (grant codes, 97/0035-01,99/0034-01 and 99/0034 02), HospitalUniversitario de Albacete, Consejeria de Sanidad; Barcelona: Sociedad Espanola de Neumologı´a y Cirugı´a Toracica, Public Health Service(grant code, R01 HL62633-01), Fondo de Investigaciones Santarias (grant codes, 97/0035-01, 99/0034-01, and 99/0034-02), Consell Interdepartamentalde Recerca i Innovacio´ Tecnolo`gica (grant code, 1999SGR 00241) Instituto de Salud Carlos III; Red deCentros de Epidemiologı´a y Salud Pu´blica, C03/09,Redde Basesmoleculares y fisiolo´gicas de lasEnfermedadesRespiratorias,C03/011and Red de Grupos Infancia y Medio Ambiente G03/176;  Huelva: Fondo de Investigaciones Santarias (grant codes, 97/0035-01, 99/0034-01, and 99/0034-02); Galdakao: Basque Health Department Oviedo: Fondo de Investigaciones Sanitaria (97/0035-02, 97/0035, 99/0034-01, 99/0034-02, 99/0034-04, 99/0034-06, 99/350, 99/0034--07), European Commission (EU-PEAL PL01237), Generalitat de Catalunya (CIRIT 1999 SGR 00214), Hospital Universitario de Albacete, Sociedad Española de Neumología y Cirugía Torácica (SEPAR R01 HL62633-01) Red de Centros de Epidemiología y Salud Pública (C03/09), Red de Bases moleculares y fisiológicas de las Enfermedades Respiratorias (C03/011) and Red de Grupos Infancia y Medio Ambiente (G03/176);97/0035-01, 99/0034-01, and99/0034-02); Sweden: Göteborg , Umea, Uppsala: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences and Allergy Research, Swedish Asthma and Allergy Foundation, Swedish Cancer and Allergy Foundation, Swedish Council for Working Life and Social Research (FAS),Switzerland: Basel Swiss National Science Foundation, Swiss Federal Office for Education and Science, Swiss National Accident Insurance Fund;  UK: Ipswich and Norwich: Asthma UK (formerly known as National Asthma Campaign) USA: Portland: American Lung Association of Oregon, Northwest Health Foundation, Collins Foundation, Merck Pharmaceutical.

ECRHS III Participants and Financial Support


Co-ordinating Centre (London): P Burney, D Jarvis, S Kapur, J Potts, R Newson
Project Management Group: P Burney (UK), D Jarvis (UK), B Leynaert (France), C Jansen ( Sweden), K Toren (Sweden), C Svanes (Norway), I Cerveri ( Italy), R de Marco ( Italy), J Anto ( Spain), J.P Zock        (Spain),N Künzli ( Switzerland), N Probst ( Switzerland), J Heinrich ( Germany), J weyler ( Belgium) T Gislasson ( Iceland)

ECHRS III Principal Investigators and senior scientific teams:
Australia: Melbourne (M.Abramson, G. Benke, S. Dharmage, B. Thompson, S. Kaushik. Belgium: South Antwerp & Antwerp City (J. Weyler, M. van Sprundel, V. Nelen, E. Van de Mieroop) Denmark: Aarhus (V. Schlunssen, T. Sigsgaard, R.Dahl) Estonia: Tartu (R. Jõgi, H.Orru) France: Bordeaux (C. Raherison, P.O Girodet) Grenoble (I. Pin, V. Siroux, J.Ferran, J.L Cracowski) Montpellier (P. Demoly,A.Bourdin, I. Vachier) Paris (B. Leynaert, D. Soussan, D. Courbon, C. Neukirch, L. Alavoine, X. Duval, I. Poirier) Germany: Erfurt (J .Heinrich, E. Becker, G. Woelke, O. Manuwald) Hamburg (H. Magnussen, D. Nowak, A-M Kirsten), Iceland: Reykjavik (T. Gislason, B. Benediktsdottir, D. Gislason, E.S Arnardottir, M. Clausen, G. Gudmundsson, L. Gudmundsdottir, H. Palsdottir, K. Olafsdottir, S. Sigmundsdottir, K. Bara-Jörundsdottir), Italy: Pavia (I .Cerveri, A.Corsico, A. Grosso, F. Albicini, E. Gini, E.M Di Vincenzo, V. Ronzoni, S. Villani, F. Campanella, F. Manzoni, L. Rossi, O. Ferraro) Turin: (M. Bugiani,  R. Bono, P. Piccioni,  R. Tassinari, V. Bellisario Verona: (R de Marco, S. Accordini, L. Calciano, L. Cazzoletti, M. Ferrari, A.M Fratta Pasini, F. Locatelli, P. Marchetti, A. Marcon, E. Montoli, G. Nguyen, M. Olivieri, C. Papadopoulou, C.Posenato, G. Pesce, P. Vallerio, G. Verlato, E. Zanolin), Netherlands: Groningen (H.M. Boezen), Norway: (C. Svanes, E.  Omenaas, A. Johannessen, T. Skorge, F.  Gomez Real ) Spain: Albacete (J. Martinez-Moratalla Rovira, E. Almar,  A. Mateos, S. García, A. Núñez, P.López, R. Sánchez, E Mancebo) Barcelona:(J M. Antó, J.P  Zock, J. Garcia-Aymerich, X. Basagaña, F. Burgos, C.  Sanjuas, J Garcia-Aymerich, S Guerra), Galdakao: N.  Muñozguren, I. Urrutia, U. Aguirre, S.  Pascual)  Huelva:(J Antonio Maldonado, A. Pereira, J. Luis Sánchez, L. Palacios, Oviedo: (F. Payo, I. Huerta, N. Sánchez, M. Fernández, B. Robles) Sweden: Göteborg (K. Torén, M. Holm, J-L Kim, A-C . Olin, A. Dahlman-Höglund), Umea (B. Forsberg, L. Braback, E. Norrman, L Modig, B Järvholm, H Bertilsson, K Franklin, C Wahlgreen, M Soderberg) Uppsala:(B Andersson, D Norback, U Spetz Nystrom, G Wieslander, G.M Bodinaa Lund, K Nisser),  Switzerland: Basel ( N.M. Probst-Hensch, N. Künzli, D. Stolz, C. Schindler, T. Rochat, J.M. Gaspoz, E. Zemp Stutz, M.Adam, C. Autenrieth, I. Curjuric, J. Dratva, A. Di Pasquale,  R. Ducret-Stich, E. Fischer, L. Grize, A. Hensel, D. Keidel, A. Kumar, M. Imboden, N. Maire, A. Mehta, H. Phuleria, M. Ragettli, M. Ritter, E. Schaffner, G.A Thun, A. Ineichen, T. Schikowski, M. Tarantino, M. Tsai, UK: London (P. Burney, D. Jarvis, S. Kapur, R. Newson, J. Potts) Ipswich: ( N. Innes) Norwich: (A. Wilson)

 
 
 

ECRHS III Financial Support

 The following grants helped to fund the local studies.

Australia: National Health & Medical Research Council, Belgium: Antwerp South, Antwerp City: Research Foundation Flanders (FWO), grant code G.0.410.08.N.10 (both sites), Estonia: Tartu- SF0180060s09 from the Estonian Ministry of Education. France: Bordeaux: Ministère de la Santé. Programme Hospitalier de Recherche Clinique (PHRC) national 2010. France: (All) Ministère de la Santé. Programme Hospitalier de Recherche Clinique (PHRC) national 2010 Bordeaux: INSERM U897 Université Bordeaux segalen Grenoble: Comitee Scientifique AGIRadom 2011. Paris: Ministère de la Santé. Programme Hospitalier de Recherche Clinique (PHRC) national 2010, Agence Nationale de la Santé, Région Ile de France, domaine d’intérêt majeur (DIM) Germany : Erfurt: German Research Foundation HE 3294/10-1 Hamburg: German Research Foundation MA 711/6-1, NO 262/7-1 Iceland: Reykjavik, The Landspitali University Hospital Research Fund, University of Iceland Research Fund, ResMed Foundation, California, USA, Orkuveita Reykjavikur (Geothermal plant), Vegagerðin (The Icelandic Road Administration (ICERA).  Italy: All Italian centres were funded by the Italian Ministry of Health, Chiesi Farmaceutici SpA, in addition Verona was funded by Cariverona foundation, Education Ministry (MIUR). Norway: Norwegian Research council grant no 214123, Western Norway Regional Health Authorities grant no 911631, Bergen Medical Research Foundation.  Spain: Fondo de Investigación Sanitaria (PS09/02457,  PS09/00716 09/01511) PS09/02185 PS09/03190), Servicio Andaluz de Salud , Sociedad Española de Neumología y Cirurgía Torácica (SEPAR 1001/2010); Sweden: All centres were funded by The Swedish Heart and Lung Foundation, The Swedish Asthma and Allergy Association, The Swedish Association against Lung and Heart Disease.Fondo de Investigación Sanitaria (PS09/02457 Barcelona:Fondo de Investigación Sanitaria (FIS PS09/00716) Galdakao: Fondo de Investigación Sanitaria (FIS 09/01511) Huelva: Fondo de Investigación Sanitaria (FIS PS09/02185) and Servicio Andaluz de Salud Oviedo: Fondo de Investigación Sanitaria (FIS PS09/03190) Sweden: All centres were funded by The Swedish Heart and Lung Foundation, The Swedish Asthma and Allergy Association, The Swedish Association against Lung and Heart Disease.  Swedish Research Council for health, working life and welfare (FORTE) Göteborg : Also received further funding from the Swedish Council  for Working life and Social Research. Umea also received funding from Vasterbotten Country Council ALF grant.  Switzerland: The Swiss National Science Foundation (grants no 33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099) The Federal office for  forest, environment and landscape, The Federal Office of Public Health, The Federal Office of Roads and Transport,  the canton’s government of Aargan, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais and Zürich, the Swiss Lung League, the canton's Lung League of Basel Stadt/ Basel, Landschaft, Geneva, Ticino, Valais and Zurich, SUVA, Freiwillige Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH, Abbott Diagnostics, European Commission 018996 (GABRIEL), Wellcome Trust WT 084703MA, UK: Medical Research Council (MRC), National Institute for Health Research through the Primary Care Research Network. Acknowledges the support of the National Institute for Health Research through the primary care research network.